
Sign up to save your podcasts
Or


Phase I results of suprachoroidal delivery of a gene vector in treating neovascular AMD are promising. A discussion with Nikolas London, MD from Retina Consultant Group in San Diego CA & Scripps Memorial Hospital La Jolla.
By Retina Synthesis4.5
88 ratings
Phase I results of suprachoroidal delivery of a gene vector in treating neovascular AMD are promising. A discussion with Nikolas London, MD from Retina Consultant Group in San Diego CA & Scripps Memorial Hospital La Jolla.

43 Listeners

18 Listeners

99 Listeners

113,168 Listeners

56,921 Listeners

5 Listeners

9,558 Listeners

12 Listeners

47,696 Listeners

51 Listeners

11 Listeners

467 Listeners

19 Listeners

0 Listeners